NCT02251145 Effects of Tipranavir (TPV) and Ritonavir (RTV) on the Pharmacokinetic Characteristics of Tenofovir Disoproxil Fumarate in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02251132 Pharmacokinetics of Tipranavir Soft Elastic Capsules (SEDDS) and Ritonavir and Their Effects on Cytochrome P-450 (3A4) in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02251119 The Pharmacodynamic/Pharmacokinetic Interaction of Tipranavir and Ritonavir With Loperamide in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02249442 Study to Determine the Pharmacokinetics on TPV/r in Subjects With Mild and Moderate Hepatic Insufficiency Status COMPLETED Phase PHASE1
NCT02249416 Comparison of the Effect of Tipranavir and Ritonavir or Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Zidovudine in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02249403 Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type Status COMPLETED Phase PHASE2
NCT02249351 Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type Status TERMINATED Phase PHASE2
NCT02249338 Effect of BIIL 284 BS on Patients With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE2
NCT02249312 The Effect of BIIL 284 BS on Induced-sputum Variables in Patients With Bronchial Asthma Status COMPLETED Phase PHASE2
NCT02249247 Effect of Treatment With BIIL 284 BS on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE2
NCT02249130 Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without Tipranavir Status COMPLETED Phase PHASE2
NCT02249117 Pharmacokinetics and Pharmacodynamics of BIWH 3 in Healthy Duffy Positive vs. Duffy Negative Male Volunteers Status COMPLETED Phase PHASE1
NCT02248883 Electrophysiological Effects of Tipranavir Co-administered With Ritonavir on the QT Interval in Healthy Female and Male Subjects Status COMPLETED Phase PHASE1
NCT02248259 Drug Drug Interaction Trial With Strong CYP3A4 Inhibitor (Itraconazole) in CYP2C19 Extensive Metabolizers and Poor Metabolizers Status COMPLETED Phase PHASE1
NCT02248220 Efficacy and Tolerability of Sifrol® (Pramipexole) in Patients With Advanced Idiopathic Parkinson's Disease Status COMPLETED Phase N/A
NCT02248207 Tolerability of Sifrol® in Ambulatory Patients Suffering From Parkinson's Disease Status COMPLETED Phase N/A
NCT02248181 Post Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson's Disease Status COMPLETED Phase N/A
NCT02248168 Post Marketing Surveillance And Special Surveillance for Mirapex® Tablet in Patients With Idiopathic Parkinson's Disease Status COMPLETED Phase N/A
NCT02248155 Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS) Status COMPLETED Phase N/A